Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/21/16 → 10/31/17 |
Funding
- University of Michigan (Prot #IM101-344)
- Bristol-Myers Squibb Company (Prot #IM101-344)
Prot #IM101-344: A Phase II Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis—A Double-Blind, Placebo-Controlled, Randomized Controlled Trial
- Varga, John (PD/PI)
Project: Research project